G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
Malaria elimination will be possible only with serious attempts to address asymptomatic infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently available drugs that can completely clear a human of P. vivax (known as "radical cure"), and that can reduce...
Główni autorzy: | Domingo, G, Satyagraha, A, Anvikar, A, Baird, K, Bancone, G, Bansil, P, Carter, N, Cheng, Q, Culpepper, J, Eziefula, C, Fukuda, M, Green, J, Hwang, J, Lacerda, M, McGray, S, Menard, D, Nosten, F, Nuchprayoon, I, Oo, N, Bualombai, P, Pumpradit, W, Qian, K, Recht, J, Roca, A, Satimai, W |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
2013
|
Podobne zapisy
-
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening
od: Athena Anderle, i wsp.
Wydane: (2018-11-01) -
Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
od: Nwe Nwe Oo, i wsp.
Wydane: (2016-01-01) -
Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers
od: Rueangweerayut, R, i wsp.
Wydane: (2017) -
Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.
od: Kalnoky, M, i wsp.
Wydane: (2017) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
od: Cindy S. Chu, i wsp.
Wydane: (2018-03-01)